Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Shugan Xiaozhi Formula Reduces Hepatic Steatosis and Stiffness in MASLD Patients with Elevated ALT: An Exploratory 24-Week Randomized Trial.

SGXZ was associated with greater reductions in hepatic steatosis, imaging-based liver stiffness, body weight, BMI, and WHR than vitamin E, with an acceptable safety profile, and these findings suggest that SGXZ represents a highly promising compound natural medicine therapeutic option for the complex metabolic diseases...

Yu-Xin Sun, Zhi-Yi Han, Can-Guang Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.